<!DOCTYPE html><html><head>   <meta>     <title>Double drug treatment raises survival rate for half of advanced melanoma to 10 years</title>   </meta>   <style>
.youtube_player_container {
    position: relative;
    width: 50%;
    padding-bottom: 26.25%;
    /* background-color: yellow; */
}
.youtube_player_frame {
    position: absolute;
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    border: 0;
}
       </style></head><body><a href="index.html"><h2>Index</h2></a><a href="https://www.theguardian.com/society/2024/sep/15/double-drug-treatment-raises-survival-rate-for-half-of-advanced-melanoma-to-10-years"><div><img style="width:400px;height=300px" src="https://i.guim.co.uk/img/media/d21aa68048afa75c9c027677f805f15ab3831272/0_250_4928_2956/master/4928.jpg?width=140&quality=85&auto=format&fit=max&s=61af6f0da23bfa4bb12affbf3980e9ea" /></div><h1>[1148486] Double drug treatment raises survival rate for half of advanced melanoma to 10 years</h1></a><div>https://www.theguardian.com/world/rss</div><div>2024-09-15 12:35:56+00:00</div><div><pre><p>Some people with form of skin cancer that once had grim prognosis now live long enough to die from other causes</p><p>More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.</p><p>The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes.</p> <a href="https://www.theguardian.com/society/2024/sep/15/double-drug-treatment-raises-survival-rate-for-half-of-advanced-melanoma-to-10-years">Continue reading...</a></pre></div></body></html>